<SEC-DOCUMENT>0001193125-17-211880-index.html : 20170623
<SEC-HEADER>0001193125-17-211880.hdr.sgml : 20170623
<ACCEPTANCE-DATETIME>20170623170100
ACCESSION NUMBER:		0001193125-17-211880
CONFORMED SUBMISSION TYPE:	8-A12B/A
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20170623
DATE AS OF CHANGE:		20170623

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Novus Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001404281
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-A12B/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36620
		FILM NUMBER:		17928284

	BUSINESS ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612
		BUSINESS PHONE:		949-238-8090

	MAIL ADDRESS:	
		STREET 1:		19900 MACARTHUR BLVD.
		STREET 2:		SUITE 550
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92612

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tokai Pharmaceuticals Inc
		DATE OF NAME CHANGE:	20070622
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-A12B/A
<SEQUENCE>1
<FILENAME>d406180d8a12ba.htm
<DESCRIPTION>8-A12B/A
<TEXT>
Document 1 - file: d406180d8a12ba.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>2
<FILENAME>d406180dex34.htm
<DESCRIPTION>EX-3.4
<TEXT>
Document 2 - file: d406180dex34.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>d406180dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
Document 3 - file: d406180dex41.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g406180page017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: g406180page017.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g406180page018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g406180page018.jpg

</DOCUMENT>
</SEC-DOCUMENT>